Taking Shandong Province as an example, this paper studies the national, provincial drug negotiations from2016to2019, analyzes the drug purchase volume, purchase amount, delivery time as well as drug availability, finds that drug negotiation has improved the drug purchase volume, purchase amount of public medical institutions, retail pharmacies. Drug prices after the negotiation dropped significantly, under the dual influence of the increase in purchase volume, the decline in prices, the availability of drugs has been improved. It is recommended to continue to promote the construction of a "dual-channel" management mechanism for designated medical institutions, retail pharmacies to further improve the availability of negotiated drugs
Key words
negotiated drugs /
Shandong Province /
accessibility
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
[1] 赖少清. 癌症的现状与困境、希望与出路——基于2017年、2018年全球癌症发病与防控态势分析[J].医学与哲学,2019,40(12):20-23.
[2] 田红,肖桂芝,刘永贵.抗肿瘤药物市场分析[J].现代药物与临床,2013,28(03):424-427.
[3] 张萍萍,朱虹,刘兰茹,曲超.基于靶向药物的医保药品谈判实践研究[J].中国卫生事业管理,2016,33(04):275-278.
[4] 陈金燃,郭凯宁,陈纯,谢焜,张勇,林永顺,陈新榕,丁榕芳.2018-2019年福建省国家谈判药品患者用药可及性调研分析[J].中国医疗保险,2020(12):59-64.
[5] 王海银,丛鹂萱,谢春艳,等.我国创新药品医保支付改革的进展及思考[J].卫生经济研究,2021,38(01):47-49.
[6] 马勇,刘梦娜,艾丹丹,等.加拿大卫生技术评估助力医保药品准入的启示[J].中国医疗保险,2022(06):125-127.